Receptor-type protein tyrosine phosphatase β regulates met phosphorylation and function in head and neck squamous cell carcinoma

Neoplasia (United States)

Volumn 14, Issue 11, 2012, Pages 1015-1022

  Xu, Yiru ^a   Zhou, Jin ^a   Carey, Thomas E ^b   Mchugh, Jonathan B ^c   Voorhees, John J ^a   Fisher, Gary J ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOMYCIN; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE BETA; SCATTER FACTOR RECEPTOR; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; GENE SILENCING; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84869170890     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.12870     Document Type: Article

References (44)

1. De Herdt MJ and Baatenburg de Jong RJ (2008). HGF and c-MET as potentialorchestrators of invasive growth in head and neck squamous cell carcinoma. Front Biosci 13, 2516-2526.
2. Hardisson D (2003). Molecular pathogenesis of head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 260, 502-508.
3. Rogers SJ, Harrington KJ, Rhys-Evans P, O-Charoenrat P, and Eccles SA (2005). Biological significance of c-erbB family oncogenes in head and neck cancer. Cancer Metastasis Rev 24, 47-69.
4. Werner JA, Rathcke IO, and Mandic R (2002). The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 19, 275-282.
5. Trusolino L and Comoglio PM (2002). Scatter-factor and semaphorin receptors: cell signalling for invasive growth. Nat Rev Cancer 2, 289-300.
6. Grotegut S, von Schweinitz D, Christofori G, and Lehembre F (2006). Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation of Snail. EMBO J 25, 3534-3545.
7. Hanzawa M, Shindoh M, Higashino F, Yasuda M, Inoue N, Hida K, Ono M, Kohgo T, Nakamura M, Notani K, et al. (2000). Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes. Carcinogenesis 21, 1079-1085.
8. Kitajo H, Shibata T, Nagayasu H, Kawano T, Hamada J, Yamashita T, and Arisue M (2003). Rho regulates the hepatocyte growth factor/scatter factorstimulated cell motility of human oral squamous cell carcinoma cells. Oncol Rep 10, 1351-1356.
9. Matsumoto K, Nakamura T, and Kramer RH (1994). Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem 269, 31807-31813.
10. Seiwert TY, Jagadeeswaran R, Faoro L, Janamanchi V, Nallasura V, El Dinali M, Yala S, Kanteti R, Cohen EE, Lingen MW, et al. (2009). The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. Cancer Res 69, 3021-3031.
11. Zeng Q, Chen S, You Z, Yang F, Carey TE, Saims D, and Wang CY (2002). Hepatocyte growth factor inhibits anoikis in head and neck squamous cell carcinoma cells by activation of ERK and Akt signaling independent of NFκB. J Biol Chem 277, 25203-25208.
12. Kim CH, Kim J, Kahng H, and Choi EC (2007). Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma. Ann Surg Oncol 14, 1565-1574.
13. Galeazzi E, Olivero M, Gervasio FC, De Stefani A, Valente G, Comoglio PM, Di Renzo MF, and Cortesina G (1997). Detection of MET oncogene/ hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol 254(suppl 1), S138-S143.
14. Kim CH, Moon SK, Bae JH, Lee JH, Han JH, Kim K, and Choi EC (2006). Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma. Acta Otolaryngol 126, 88-94.
15. Lo Muzio L, Leonardi R, Mignogna MD, Pannone G, Rubini C, Pieramici T, Trevisiol L, Ferrari F, Serpico R, Testa N, et al. (2004). Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma. Anticancer Res 24, 1063-1069.
16. Marshall DD and Kornberg LJ (1998). Over expression of scatter factor and its receptor (c-met) in oral squamous cell carcinoma. Laryngoscope 108, 1413-1417.
17. Morello S, Olivero M, Aimetti M, Bernardi M, Berrone S, Di Renzo MF, and Giordano S (2001). MET receptor is overexpressed but not mutated in oral squamous cell carcinomas. J Cell Physiol 189, 285-290.
18. Sawatsubashi M, Sasatomi E, Mizokami H, Tokunaga O, and Shin T (1998). Expression of c-Met in laryngeal carcinoma. Virchows Arch 432, 331-335.
19. Di Renzo MF, Olivero M, Martone T, Maffe A, Maggiora P, Stefani AD, Valente G, Giordano S, Cortesina G, and Comoglio PM (2000). Somatic mutations of the MET oncogene are selected during metastatic spread of human HNSC carcinomas. Oncogene 19, 1547-1555.
20. Chen YS, Wang JT, Chang YF, Liu BY, Wang YP, Sun A, and Chiang CP (2004). Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan. J Oral PatholMed 33, 209-217.
21. Kalyankrishna S and Grandis JR (2006). Epidermal growth factor receptor biology in head and neck cancer. J Clin Oncol 24, 2666-2672.
22. Uchida D, Kawamata H, Omotehara F, Nakashiro K, Kimura-Yanagawa T, Hino S, Begum NM, Hoque MO, Yoshida H, Sato M, et al. (2001). Role of HGF/c-met system in invasion and metastasis of oral squamous cell carcinoma cells in vitro and its clinical significance. Int J Cancer 93, 489-496.
23. Kim CH, Lee JS, Kang SO, Bae JH, Hong SP, and Kahng H (2007). Serum hepatocyte growth factor as a marker of tumor activity in head and neck squamous cell carcinoma. Oral Oncol 43, 1021-1025.
24. Otsuka T, Takayama H, Sharp R, Celli G, LaRochelle WJ, Bottaro DP, Ellmore N, Vieira W, Owens JW, Anver M, et al. (1998).C-Met autocrine activation induces development of malignant melanoma and acquisition of the metastatic phenotype. Cancer Res 58, 5157-5167.
25. Mazzone M and Comoglio PM (2006). The Met pathway: master switch and drug target in cancer progression. FASEB J 20, 1611-1621.
26. Peschard P and Park M (2007). From Tpr-Met to Met, tumorigenesis and tubes. Oncogene 26, 1276-1285.
27. Murai M, Shen X, Huang L, Carpenter WM, Lin CS, Silverman S, Regezi J, and Kramer RH (2004). Over expression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion. Int J Oncol 25, 831-840.
28. Petrone A and Sap J (2000). Emerging issues in receptor protein tyrosine phosphatase function: lifting fog or simply shifting? J Cell Sci 113(pt 13), 2345-2354.
29. Schaapveld R, Wieringa B, and Hendriks W (1997). Receptor-like protein tyrosine phosphatases: alike and yet so different. Mol Biol Rep 24, 247-262.
30. Kaplan R, Morse B, Huebner K, Croce C, Howk R, Ravera M, Ricca G, Jaye M, and Schlessinger J (1990). Cloning of three human tyrosine phosphatases reveals a multigene family of receptor-linked protein-tyrosine-phosphatases expressed in brain. Proc Natl Acad Sci USA 87, 7000-7004.
31. Krueger NX, Streuli M, and Saito H (1990). Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. EMBO J 9, 3241-3252.
32. Harder KW, Anderson LL, Duncan AM, and Jirik FR (1992). The gene for receptor-like protein tyrosine phosphatase (PTPRB) is assigned to chromosome 12q15→q21. Cytogenet Cell Genet 61, 269-270.
33. Autero M, Saharinen J, Pessa-Morikawa T, Soula-Rothhut M, Oetken C, Gassmann M, Bergman M, Alitalo K, Burn P, Gahmberg CG, et al. (1994). Tyrosine phosphorylation of CD45 phosphotyrosine phosphatase by p50csk kinase creates a binding site for p56lck tyrosine kinase and activates the phosphatase. Mol Cell Biol 14, 1308-1321.
34. Carey TE, Van Dyke DL, Worsham MJ, Bradford CR, Babu VR, Schwartz DR, Hsu S, and Baker SR (1989). Characterization of human laryngeal primary and metastatic squamous cell carcinoma cell lines UM-SCC-17A and UM-SCC-17B. Cancer Res 49, 6098-6107.
35. Balavenkatraman KK, Jandt E, Friedrich K, Kautenburger T, Pool-Zobel BL, Ostman A, and Bohmer FD (2006). DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients. Oncogene 25, 6319-6324.
36. Carey T (1994). Head and neck tumor cell lines. In Atlas of Human Tumor Cell Lines. RJ Hay, J-G Park, and A Gazdar (Eds). Academic Press, Inc, New York. pp. 79-120.
37. Ponzetto C, Bardelli A, Zhen Z, Maina F, dalla Zonca P, Giordano S, Graziani A, Panayotou G, and Comoglio PM (1994). A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family. Cell 77, 261-271.
38. Zhu H, Naujokas MA, Fixman ED, Torossian K, and Park M (1994). Tyrosine 1356 in the carboxyl-terminal tail of the HGF/SF receptor is essential for the transduction of signals for cell motility and morphogenesis. J Biol Chem 269, 29943-29948.
39. Matsumoto K, Hashimoto K, Yoshikawa K, and Nakamura T (1991). Marked stimulation of growth and motility of human keratinocytes by hepatocyte growth factor. Exp Cell Res 196, 114-120.
40. Shimaoka S, Tsuboi R, Jindo T, Imai R, Takamori K, Rubin JS, and Ogawa H (1995). Hepatocyte growth factor/scatter factor expressed in follicular papilla cells stimulates human hair growth in vitro. J Cell Physiol 165, 333-338.
41. Tajima H, Matsumoto K, and Nakamura T (1992). Regulation of cell growth and motility by hepatocyte growth factor and receptor expression in various cell species. Exp Cell Res 202, 423-431.
42. Christensen JG, Schreck R, Burrows J, Kuruganti P, Chan E, Le P, Chen J, Wang X, Ruslim L, Blake R, et al. (2003). A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res 63, 7345-7355.
43. Lesko E and Majka M (2008). The biological role of HGF-MET axis in tumor growth and development of metastasis. Front Biosci 13, 1271-1280.
44. Ma PC, Maulik G, Christensen J, and Salgia R (2003). c-Met: structure, functions and potential for therapeutic inhibition. Cancer Metastasis Rev 22, 309-325.